recro_logo.jpg
Recro Pharma Reports Second Quarter 2014 Financial Results
August 12, 2014 07:00 ET | Recro Pharma, Inc.
MALVERN, Pa., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain,...
recro_logo.jpg
Recro Pharma Added to Russell Microcap(R) Index
June 30, 2014 07:00 ET | Recro Pharma, Inc.
MALVERN, Pa., June 30, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain,...
recro_logo.jpg
Recro Pharma Announces Dosing of First Patient in Phase IIb Clinical Trial of Dex-IN for Treatment of Acute Pain Following Surgery
June 17, 2014 07:30 ET | Recro Pharma, Inc.
MALVERN, Pa., June 17, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain,...
recro_logo.jpg
Recro Pharma Reports First Quarter 2014 Financial Results
May 12, 2014 07:30 ET | Recro Pharma, Inc.
MALVERN, Pa., May 12, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain,...
recro_logo.jpg
Recro Pharma Announces New Board Members
March 13, 2014 13:23 ET | Recro Pharma, Inc.
MALVERN, Pa., March 13, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for post-operative pain, today...
recro_logo.jpg
Recro Pharma Announces Closing of Initial Public Offering
March 12, 2014 16:05 ET | Recro Pharma, Inc.
MALVERN, Pa., March 12, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, today...
recro_logo.jpg
Recro Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
March 11, 2014 08:00 ET | Recro Pharma, Inc.
MALVERN, Pa., March 11, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, today...
recro_logo.jpg
Recro Pharma Announces Pricing of Its Initial Public Offering
March 06, 2014 20:44 ET | Recro Pharma, Inc.
MALVERN, Pa., March 6, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, today...